Home / Market News / $MASS

$MASS news and market catalysts

The 6 most recent market catalysts affecting $MASS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

6 catalysts 1 high impact 4 bullish 0 bearish Healthcare Equipment & Supplies
Sep 10, 2026 Corporate Catalyst Neutral Impact 55
Canaccord Genuity Initiates Coverage On 908 Devices with Buy Rating, Announces Price Target of $13.5
Canaccord Genuity's initiation of coverage on 908 Devices with a 'Buy' rating and a $13.5 price target signals a positive outlook from a reputable financial institution. This event…
Aug 12, 2026 Corporate Catalyst Bullish Impact 55
Stifel Maintains Buy on 908 Devices, Raises Price Target to $12
Stifel analyst Daniel Arias has maintained a 'Buy' rating on 908 Devices (MASS) and raised the price target from $10 to $12. This upgrade signals increased confidence from a promin…
Aug 12, 2026 Corporate Catalyst Bullish Impact 55
Roth Capital Maintains Buy on 908 Devices, Raises Price Target to $13
Roth Capital analyst Max Masucci maintained a 'Buy' rating on 908 Devices (MASS) and raised the price target from $11 to $13. This action signals continued confidence in the compan…
Aug 11, 2026 Corporate Catalyst Bullish Impact 85
908 Devices shares are trading higher after the company reported better-than-expected Q2 sales results and raised its FY26 sales guidance.
This headline represents a strong positive corporate catalyst for 908 Devices (MASS). Better-than-expected sales and raised guidance signal healthy demand for their products and ef…
Aug 11, 2026 Corporate Catalyst Bullish Impact 75
908 Devices Raises FY2026 Sales Guidance from $67.000M-$70.000M to $68.000M-$70.000M vs $68.585M Est
908 Devices (MASS) has updated its FY2026 sales guidance, raising the lower end of the range from $67.0 million to $68.0 million, while keeping the upper end at $70.0 million. This…
Jul 29, 2026 Corporate Catalyst Neutral Impact 55
Roth Capital Initiates Coverage On 908 Devices with Buy Rating, Announces Price Target of $11
Roth Capital's initiation of coverage on 908 Devices (MASS) with a 'Buy' rating and an $11 price target is a positive development for the company. Analyst coverage, especially with…
 Join the waitlist for full signal validation →

New to reading filings? What an SEC 8-K is and why it moves prices

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.